Drug Shortage Report for AURO-OLANZAPINE ODT

Last updated on 2022-02-09 History
Report ID 56349
Drug Identification Number 02448742
Brand name AURO-OLANZAPINE ODT
Common or Proper name OLANZAPINE
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) OLANZAPINE
Strength(s) 15MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 3X10
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-07-25
Estimated end date 2022-02-10
Actual end date 2022-01-07
Shortage status Resolved
Updated date 2022-02-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2020-05-22 English Compare
v22 2020-05-22 French Compare
v23 2020-06-08 English Compare
v24 2020-06-08 French Compare
v25 2020-10-14 English Compare
v26 2020-10-14 French Compare
v27 2020-11-24 English Compare
v28 2020-11-24 French Compare
v29 2020-11-24 English Compare
v30 2020-11-24 French Compare
v31 2021-01-29 English Compare
v32 2021-01-29 French Compare
v33 2021-03-31 English Compare
v34 2021-03-31 French Compare
v35 2021-08-03 English Compare
v36 2021-08-03 French Compare
v37 2021-10-01 English Compare
v38 2021-10-01 French Compare
v39 2021-10-29 English Compare
v40 2021-10-29 French Compare

Showing 21 to 40 of 44